|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02480920 |
|
Date of registration:
|
19/06/2015 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Adherence to New Oral Anticoagulation Therapy in Turkey
NOAC-TR |
|
Scientific title:
|
Drug Adherence in Patients Taking New Oral Anticoagulation Therapy in Turkey |
|
Date of first enrolment:
|
July 2015 |
|
Target sample size:
|
2738 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02480920 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Turkey
| | | | | | | |
|
Contacts
|
|
Name:
|
Volkan Emren, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Cardiovascular Academy Society, Izmir, Turkey |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients >18 years old
- Outpatients using a NOAC for at least 3 months duration, with a primary diagnosis of
new-onset, non-valvular atrial fibrillation
- Patients signed patient informed sheet and informed consent form
Exclusion Criteria:
- Patients under 18 years old
- Patients refused to sign informed consent form
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Atrial Fibrillation
|
|
Primary Outcome(s)
|
|
Compliance of NOACs in Turkish Population
[Time Frame: 10 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|